Systematic review shows cenegermin improves corneal sensitivity in neurotrophic keratopathy, suggesting therapeutic potential.
An 8-week course of cenegermin led to improvements in CS and CI in patients with NK, with greater relative gains observed among those patients with more severe disease. While study design heterogeneity and small sample sizes may limit the generalizability of these findings, the data support cenegermin's role in promoting corneal nerve regeneration.
No takes yet. Share an insight, caveat, or question.
Fung et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: